GRAL GRAIL, Inc.

NAS · US · Healthcare · Diagnostics & Research · grail.com

154.08USD+7.55%Mkt Cap: 6.88B $P/E: —1d ago

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individ…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$41.58BUSDP/E 37.0

MTD

Mettler-Toledo International Inc.

$30.89BUSDP/E 34.7

DGX

Quest Diagnostics Incorporated

$25.63BUSDP/E 24.7

Guardant Health, Inc.

$25.12BUSD

Labcorp Holdings Inc.

Medpace Holdings, Inc.

$17.32BUSDP/E 36.4

CRL

Charles River Laboratories International, Inc.

$14.84BUSD

ERF

Eurofins Scientific SE

$14.05BUSDP/E 26.2

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap6.88B USD

Enterprise Value5.63B USD

Revenue (TTM)165.26M USD

Gross Profit-62.57M USD

Net Income (TTM)-408.35M USD

Revenue/Share4.11 USD

Last Price154.08 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees910

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-17.39

PEG—

EV/EBITDA-14.87

EV/Revenue34.06

P/S38.72

P/B2.52

EPS (TTM)-9.70

EPS (Forward)-8.24

52W Range

41.5098% of range156.49

52W High156.49 USD

52W Low41.50 USD

Profitability

Gross Margin-42.52%

Oper. Margin-332.00%

EBITDA Margin-229.02%

Profit Margin-277.47%

ROE-15.84%

ROA-13.97%

Growth

Revenue Growth25.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF-299.01M USD

CapEx (TTM)909.00K USD

FCF Margin-62.68%

FCF Yield-1.51%

Net Debt-770.30M USD

Net Debt/EBITDA2.04

Balance Sheet

Debt/Equity0.02

Current Ratio10.95

Quick Ratio10.55

Book Value/Sh56.93 USD

Cash/Share19.29 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.1 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)112.40 USD

Upside (mean)-27.1%

Target Range60.00 USD – 175.00 USD

60.00-27.1% to mean175.00

# Analysts10

Ownership

Shares Out.44.67M

Float34.34M

Insiders5.00%

Institutions86.26%

Short Interest

Short Ratio12.3d

Short % Float19.48%

Short % Out.19.18%

Shares Short8.57M

Short (prev mo.)8.16M

Technical

SMA 5084.83 (+81.6%)

SMA 20073.68 (+109.1%)

Beta3.25

S&P 52W Chg14.58%

Avg Vol (30d)1.13M

Avg Vol (10d)1.74M

Technical Indicators

RSI (14)84.4

MACD18.7028

MACD Signal13.7148

MACD Hist.+4.9880

BB Upper161.98 USD

BB Middle104.59 USD

BB Lower47.21 USD

BB Width109.73%

ATR (14)9.263 USD

Vol Ratio (20d)1.06x